Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-28T05:20:26.007Z Has data issue: false hasContentIssue false

Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  29 January 2018

H. Hermesh
Affiliation:
Gehah Psychiatrie Hospital, Beilinson Medical Center, Petah Tikva 49100, Israel
A. Shalev
Affiliation:
Gehah Psychiatrie Hospital, Beilinson Medical Center, Petah Tikva 49100, Israel
A. Weizman
Affiliation:
Gehah Psychiatrie Hospital, Beilinson Medical Center, Petah Tikva 49100, Israel
D. Aizenberg
Affiliation:
Gehah Psychiatrie Hospital, Beilinson Medical Center, Petah Tikva 49100, Israel
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

References

Jesse, S. S. & Anderson, F. (1983) ECT in the neuroleptic malignant syndrome. Journal of Clinical Psychiatry, 44, 186188.Google Scholar
Lazarus, A. (1986) Treatment of neuroleptic malignant syndrome with electroconvulsive therapy. Journal of Nervous and Mental Diseases, 174, 4749.Google Scholar
Lerer, B. & Belmaker, R. H. (1982) Receptors and the mechanism of action of ECT. Biological Psychiatry, 17, 497511.Google Scholar
Powers, P., Scott-Douglass, T. & Waziri, R. (1976) Hyperpyrexia in catatonic states. Diseases of the Nervous System, 37, 359361.Google Scholar
Regestein, G., Alpert, J. & Reich, P. (1977) Catatonic stupor with disastrous outcome. Journal of the American Medical Association, 238, 618620.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.